Abstract
In addition to its high proportion of oleic acid (which is considered as “neutral” in terms of cardioprotection), extra virgin olive oil is rich in phenolic compounds, which other vegetable oils do not contain. This review critically appraises the current scientific evidence of a healthful role of olive phenols, with particular emphasis on hydroxytyrosol and related molecules.
Keywords: Olive oil, polyphenols, hydroxytyrosol, Mediterranean diet, cardiovascular disease, oleic acid, micronutrients, antioxidant, lipid-laden, plaques, brevity, organoleptic, peroxidation, mutagenic, ascorbate, cardioprotection, scavenging, chelation, electrophoretic, glucuronide
Current Pharmaceutical Design
Title: Extra Virgin Olive Oils Polyphenols: Biological Activities
Volume: 17 Issue: 8
Author(s): Francesco Visioli and Elena Bernardini
Affiliation:
Keywords: Olive oil, polyphenols, hydroxytyrosol, Mediterranean diet, cardiovascular disease, oleic acid, micronutrients, antioxidant, lipid-laden, plaques, brevity, organoleptic, peroxidation, mutagenic, ascorbate, cardioprotection, scavenging, chelation, electrophoretic, glucuronide
Abstract: In addition to its high proportion of oleic acid (which is considered as “neutral” in terms of cardioprotection), extra virgin olive oil is rich in phenolic compounds, which other vegetable oils do not contain. This review critically appraises the current scientific evidence of a healthful role of olive phenols, with particular emphasis on hydroxytyrosol and related molecules.
Export Options
About this article
Cite this article as:
Visioli Francesco and Bernardini Elena, Extra Virgin Olive Oils Polyphenols: Biological Activities, Current Pharmaceutical Design 2011; 17 (8) . https://dx.doi.org/10.2174/138161211795428885
DOI https://dx.doi.org/10.2174/138161211795428885 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial [Hot Topic: Anti-Platelet Therapy (Guest Editor: Susan S. Smyth)]
Current Drug Targets Combined Dyslipidemia: Should the Focus be LDL Cholesterol or Atherogenic Dyslipidemia?
Current Pharmaceutical Design Pathophysiology of Myocardial Infarction and Acute Management Strategies
Cardiovascular & Hematological Agents in Medicinal Chemistry The Mechanisms Behind the Biological Activity of Flavonoids
Current Medicinal Chemistry Putative Immune Regulatory Role of Statins
Current Immunology Reviews (Discontinued) Nutraceutical: A Drug, Dietary Supplement and Food Ingredient
Current Pharmacogenomics and Personalized Medicine How to Investigate the Vascular Changes in Resistant Hypertension
Current Hypertension Reviews Structural MRI Predictors of Late-Life Cognition Differ Across African Americans, Hispanics, and Whites
Current Alzheimer Research Cancer Prevention with Promising Natural Products: Mechanisms of Action and Molecular Targets
Anti-Cancer Agents in Medicinal Chemistry Nitric Oxide and Protection against Cardiac Ischemia
Current Pharmaceutical Design Interplay of Carotenoids with Cigarette Smoking: Implications in Lung Cancer
Current Medicinal Chemistry Novel Phosphodiesterase Inhibitors in the Treatment of Chronic Obstructive Pulmonary Disease
Current Respiratory Medicine Reviews Non-Transferrin Bound Iron - Determination in Biological Material and Clinical Implications
Current Pharmaceutical Analysis A Review on the Use of Statins and Tocotrienols, Individually or in Combination for the Treatment of Osteoporosis
Current Drug Targets Recent Advances in the Treatment of Helicobacter pylori Infection
Recent Patents on Anti-Infective Drug Discovery Editorial: Inflammation and Heart Diseases
Current Pharmaceutical Design Current Nanotechnological Approaches for an Effective Delivery of Bioactive Drug Molecules to Overcome Drug Resistance Tuberculosis
Current Pharmaceutical Design Editorial (Thematic Issue: Modifying Cardiovascular Risk Factors: Newer Advances in Cardiovascular Metabolism and Diagnostic Technologies)
Current Pharmaceutical Design Immunophilins and Cardiovascular Complications
Current Medicinal Chemistry Novel Oral Anticoagulants in Atrial Fibrillation: Update on Apixaban
Current Cardiology Reviews